Deliver Your News to the World

News

Distribute Your News

  • Every day, hundreds of individuals and companies choose WebWire to distribute their news.
  • WebWire places your news within numerous highly trafficked news search engines generating leads and publicity.
  • Submit Your Release Now!

Health Care / Hospitals

Releases published in the last 30 days. RSS 0.91 Feed

Page 1 of 7

Catherine Estrampes appointed President & CEO of GE Healthcare Europe
Catherine Estrampes appointed President & CEO of GE Healthcare Europe
7/26/2017 9:05:06 AM
Catherine Estrampes has been announced as President & CEO for GE Healthcare Europe, effective on 1 October 2017, reporting to Kieran Murphy, GE Healthcare CEO.
Philips and Italian Fatebenefratelli hospital sign multiyear strategic partnership to enable family-centered care for mother and child
Philips and Italian Fatebenefratelli hospital sign multiyear strategic partnership to enable family-centered care for mother and child
7/26/2017 8:53:34 AM
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the historic San Giovanni Calibita Fatebenefratelli Hospital in Rome today announced a long-term strategic partnership to introduce state-of-the-art Family Centered Care (FCC) at the hospital.
HIVMA Urges Senate Not to Proceed with Affordable Care Act Repeal
HIVMA Urges Senate Not to Proceed with Affordable Care Act Repeal
7/26/2017 8:45:58 AM
The HIV Medicine Association urges our senators to stand up for the health of millions of Americans, including the 1.2 million living with HIV in the United States, by rejecting the Motion to Proceed with a vote on either the Better Care Reconciliation Act or the Obamacare Repeal Reconciliation Act.
Safety of medical devices not often evaluated by sex, age, or race
Safety of medical devices not often evaluated by sex, age, or race
7/26/2017 8:36:15 AM
Researchers at Yale and the University of California-San Francisco have found that few medical devices are analyzed to consider the influence of their users’ sex, age, or race on safety and effectiveness.
Survey: Older Canadians most likely to benefit from digital health technology; least likely to adopt
Survey: Older Canadians most likely to benefit from digital health technology; least likely to adopt
7/26/2017 8:25:40 AM
Canada is bracing for a “Silver Tsunami” as the number of seniors now exceeds that of children in the country for the first time ever. Healthcare, more than any other service, is expected to feel the biggest impact of the population wave.
Know Hunger Chicago Holds Snap Challenge With Chicago Urban League and Metropolitan Board
Know Hunger Chicago Holds Snap Challenge With Chicago Urban League and Metropolitan Board
7/25/2017 12:31:27 PM
Tyson Foods, Inc. and Chicago Urban League participated in the  KNOW Hunger Challenge  over the weekend as part of the KNOW Hunger Chicago project to educate community leaders on the struggles Supplemental Nutrition Assistance Program (SNAP) recipients go through to feed themselves and their families.
Abbott Initiates Clinical Trial of Three-Month Dual Antiplatelet Therapy Following Implantation with XIENCE Coronary Stent
Abbott Initiates Clinical Trial of Three-Month Dual Antiplatelet Therapy Following Implantation with XIENCE Coronary Stent
7/25/2017 12:16:39 PM
Abbott today announced that the first patient has been enrolled in a clinical study evaluating the short-term use of common blood thinning medicines, called dual antiplatelet therapy (DAPT), after receiving a XIENCE everolimus-eluting coronary stent.  The study, called XIENCE Short DAPT, will evaluate if three months of DAPT is non-inferior to the current standard of 12 …
ViiV Healthcare announces superior efficacy of dolutegravir versus lopinavir/ritonavir in second-line HIV treatment in resource-limited settings
ViiV Healthcare announces superior efficacy of dolutegravir versus lopinavir/ritonavir in second-line HIV treatment in resource-limited settings
7/25/2017 12:04:56 PM
ViiV Healthcare, the global specialist HIV company, majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced positive interim results from DAWNING.
Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive Vaccine
Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive Vaccine
7/25/2017 10:20:19 AM
Johnson & Johnson announced encouraging first-in-human clinical data for an investigational HIV-1 vaccine regimen in development at its Janssen Pharmaceutical Companies.
Evolution of pregnancy may be key to better reproductive technologies today
Evolution of pregnancy may be key to better reproductive technologies today
7/25/2017 10:11:35 AM
Pregnancy in humans has typically been studied as an anti-inflammatory process, where a mother’s immune system is suppressed to protect the fetus from attack.
Elsevier updates “Bretherick’s Handbook of Reactive Chemical Hazards“
Elsevier updates “Bretherick’s Handbook of Reactive Chemical Hazards“
7/25/2017 10:03:48 AM
Elsevier, the information analytics company specializing in science and health, announced the publication of the eighth edition of Bretherick’s Handbook of Reactive Chemical Hazards, edited by Peter G.
HealthCombix Expands Healthcare Blockchain Advisory Team
HealthCombix Expands Healthcare Blockchain Advisory Team
7/25/2017 10:00:00 AM
HealthCombix, a global decentralized healthcare blockchain network development company, announced today both Dr. Andreas Freund, PhD and Mr. Peter Nichol have joined the company Advisory Board.
TELUS Health empowers Canadians to better manage their medications
TELUS Health empowers Canadians to better manage their medications
7/25/2017 9:55:06 AM
TELUS Health today announced that Pharma Space, its technology service that helps patients manage their prescriptions through features like scheduling online reminders and automatic refills is now being accessed by more than 300,000 customers.
UNESCO announces winners of 2017 International Research in the Life Sciences Prize
UNESCO announces winners of 2017 International Research in the Life Sciences Prize
7/24/2017 4:20:37 PM
The Director-General of UNESCO, Irina Bokova, has announced the laureates of the  UNESCO–Equatorial Guinea International Prize for Research in the Life Sciences  for 2017.
UNICEF thanks the State of Kuwait for its support to Yemen’s children
UNICEF thanks the State of Kuwait for its support to Yemen’s children
7/24/2017 4:15:31 PM
As the humanitarian crisis in Yemen deepens and with no end in sight, UNICEF welcomes the latest contribution of over US$2 million from the State of Kuwait to support children affected by the acute watery diarrhoea /cholera outbreak.
GSK submits US regulatory filing of Arnuity Ellipta in children with asthma
GSK submits US regulatory filing of Arnuity Ellipta in children with asthma
7/24/2017 4:03:42 PM
Arnuity Ellipta (fluticasone furoate 100mcg and 200mcg) is an inhaled corticosteroid (ICS) which was approved in the US in August 2014 for the maintenance treatment of asthma in patients aged 12 years and older.
Pfizer Announces Positive Top-Line Results from The Comparative Reflections B7391003 Study for PF-06439535, a Potential Biosimilar to Avastin®1 (bevacizumab)
Pfizer Announces Positive Top-Line Results from The Comparative Reflections B7391003 Study for PF-06439535, a Potential Biosimilar to Avastin®1 (bevacizumab)
7/24/2017 3:11:20 PM
Pfizer Inc. (NYSE:PFE) today announced that the REFLECTIONS B7391003 study, a comparative, confirmatory safety and efficacy study of PF-06439535 versus Avastin® (bevacizumab), met its primary objective.
Data Published in The Lancet Shows High Efficacy at 96 Weeks for First Investigational Two-Drug, Long-Acting Injectable HIV Regimen
Data Published in The Lancet Shows High Efficacy at 96 Weeks for First Investigational Two-Drug, Long-Acting Injectable HIV Regimen
7/24/2017 12:34:00 PM
Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) today announced that a regimen of two investigational long-acting, injectable formulations of HIV medicines —Janssen’s rilpivirine and ViiV Healthcare’s cabotegravir — given together every 4 or 8 weeks was as effective as 3-drug oral antiretroviral therapy (ART) at …
EMLab P&K’s Seattle Area Laboratory Celebrates 13 years, Supporting Washington with Local Mold Analysis
EMLab P&K’s Seattle Area Laboratory Celebrates 13 years, Supporting Washington with Local Mold Analysis
7/24/2017 11:32:33 AM
EMLab P&K, a TestAmerica company and the leading commercial indoor air quality (IAQ) laboratory in North America, marks thirteen years of serving communities throughout Washington.
Research Shows One Aspect of the Affordable Care Act Has No Significant Impact on Emergency Department Patient Visits
Research Shows One Aspect of the Affordable Care Act Has No Significant Impact on Emergency Department Patient Visits
7/24/2017 9:36:34 AM
As the debate surrounding the Affordable Care Act (ACA) looms in the U.S. Congress, Johns Hopkins researchers are weighing in on one aspect of the law.